The global nanobiomaterials market is witnessing substantial growth, driven by their increasing application in drug delivery, regenerative medicine, and diagnostics. According to a report by Allied Market Research, this market is projected to reach $11.9 billion by 2025, registering a CAGR of 12.3% from 2018 to 2025. The development of advanced nanobiomaterials, especially for targeted therapy, has spurred significant interest. Despite potential challenges such as high costs and stringent regulatory issues, innovative applications in areas like tissue engineering, orthopedics, and dentistry, along with increased investment in nanotechnology research, present substantial growth opportunities.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by